Results 221 to 230 of about 523,743 (349)

Otorhinolaryngology - Head and Neck Surgery [PDF]

, 2013
丸山 元祥, 伏木 宏彰, 將積 日出夫, 小林 健二, 武田 精一, 浅井 正嗣, 渡辺 行雄, 石田 正幸, 藤坂 実千郎, 西田 悠, 金沢 佑治, 髙倉 大匡   +11 more
core   +1 more source

Essential Equipment for Baseline Otolaryngology-Head and Neck Surgery Care: A Global Cross-Sectional Survey. [PDF]

Laryngoscope Investig Otolaryngol
Srinivasan T, Cherches A, Seguya A, Pandey A, Fei-Zhang D, Nuss S, Elwell Z, Adeyemo A, Alkire BC, Bangash AH, Cahill G, Daudu D, Der Mussa C, Din T, Fagan JJ, Hapunda R, Ibekwe T, Maina I, Mukuzi A, Patterson RH, Shaye DA, Smith ER, Sprow H, Waterworth CJ, Wiedermann JP, Xu MJ, Zalaquett N, Kahinga AA, Tamir SO, Global OHNS Initiative.   +29 more
europepmc   +1 more source

Prevention of Neural Complications in Head and Neck Surgery.

, 1995
Keiichi Ichimura
openalex   +2 more sources

Molten‐Salt‐Mediated Synthesis of Atomic Manganese/Cobalt Catalysts on Bioceramic Microparticles for Catalytic Anti‐Osteoarthritis Treatments

Advanced Science, EarlyView.
Microparticle‐based antioxidants capable of scavenging multiple reactive oxygen species (ROS) have been developed. When retained within the articular cavity of osteoarthritic mice, Mn‐ or Co‐AKT‐MPs protect the inherent homeostasis between cartilage anabolism and catabolism, and inhibit synovial inflammation.
Ronghui Deng, Zining Zhang, Aijun Wu, Chaoqin Shu, Shitang Song, Fuzhen Yuan, Zijie Xu, Meng Yang, Jing Ye, Yifan Song, Yufang Zhu, Jia‐Kuo Yu   +11 more
wiley   +1 more source

Present Status of Intraoperative Blood Transfusion in Otolaryngology and Head & Neck Surgery.

, 1995
Naomi Kato, Atsushi Sakakura, Mariko Okamoto, Ken Nakai, Osamu Noi, Kazuo Makimoto, Hiroaki Takahashi   +6 more
openalex   +2 more sources

Nasotracheal intubation for head and neck surgery [PDF]

, 2003
R. Williamson
openalex   +1 more source

Mortalin and PINK1/Parkin‐Mediated Mitophagy Represent Ovarian Cancer‐Selective Targets for Drug Development

Advanced Science, EarlyView.
Ovarian cancer patients with high levels of mortalin protein in their tumors have worse survival. The investigational drug SHetA2 interferes with mortalin's support of mitochondria. The resulting mitochondrial damage causes a process called mitophagy that contributes to how SHetA2 kills cancer cells. Noncancerous cells repair their mitochondria through
Vishal Chandra, Justin Garland, Rajani Rai, Donghua Zhao, Charuksha Walgama, Sadagopan Krishnan, Andrew T. Long, Tongzu Liu, Laura Adhikari, Doris M. Benbrook   +9 more
wiley   +1 more source

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery. [PDF]

Front Pharmacol
Ji Z, Wang X, Wang J.
europepmc   +1 more source

A phase II study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for advanced squamous cell carcinoma of the head and neck

, 2000
John Waldron, Brian O’Sullivan, Jonathan C. Irish, Padraig Warde, Patrick Gullane, Susanna Sellmann, Fangqin Liu, David G. Payne, B. Cummings   +8 more
openalex   +1 more source

WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma

Advanced Science, EarlyView.
This study reveals a new mechanism by which PDIA3P1 regulates the progression of esophageal squamous cell carcinoma (ESCC). PDIA3P1 upregulates the expression of GLUT1 and HK2, promoting glycolysis and lactate production. Lactate upregulates the lactylation level of histone H4K8 and activates the transcription of target gene BMP7, ultimately ...
Tao Huang, Qi You, Jiawei Liu, Xuguang Shen, Dengjun Huang, Xinlu Tao, Zhijie He, Chengwei Wu, Xinran Xi, Shouqiang Yu, Feng Liu, Zhihao Wu, Wenjun Mao, Shaojin Zhu   +13 more
wiley   +1 more source